AKT1 and Insulin resistance: In murine diabetic tissues, expression of ANXA1 is decreased allowing for the activation of RhoA, while treatment with hrANXA1 inhibits RhoA activity, decreases insulin resistance, and restores Akt and eNOS signaling.